chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up at 3:00 am on the morning of 3/5/21, about 12 hours after receiving my second Moderna Covid-19 vaccine, with SEVERE pain in my left arm, fever (101), terrible body pain, chills, fatigue.  Any movement of my left arm was excruciating. Any body movements were very painful.  I was bed ridden for 2 days.  My hands hurt like hell. No swelling anywhere.  I couldn?t work for a week. For six months thereafter, I could not raise my hands or arms above my shoulders for the nerve pain damage in the lower muscle of my left arm.  I don?t know why the lower muscle of the right arm wa also incomassitated, but it did not have the nerve pain.  My hands, wrists and knuckles are so painful it hurts to wipe my bum or drive a car.  Getting dressed is always a painful, tearful experience.  Th doctor has me on Methylprednisolone for the pain so I can keep working.  It appear s this pain is permanent.
Nurse drawing up vaccine only drew up a half dose instead of the full dose. Patient came back in to get the other half
Pt. received his first Covid JJ shot on 6-1-22.  He walked to the front of the pharmacy and passed out against glass shelving. The staff called EMS as patient sat on the floor very pale and shaken. Staff members put ice on his neck and head and offered water and crackers. Although he refused to leave by EMS he did sit the ambulance for about 30 minutes. We checked on him before he was driven home and was doing will.
11/29 Child had brief episode of stiffness, arching of back & some twitching of feet. Eyes didn't roll, aware of mom's presence. Noted a rash and took him to  ER. Rash was not noted when arrived at ER.
Information has been received from a physician for the Pregnancy Registry for GARDASIL, concerning a 20 year old female who on 24-SEP-2008 was vaccinated with GARDASIL 0.5ml IM (Lot# 661044/0548X) (therapy site unknown).  The patient was pregnant and sought medical attention.  On 08-OCT-2008 the pregnancy was terminated.  The pregnancy was not terminated because of complications but rather personal choice.  The patient had no medical history and drug reactions/allergies.  Concomitant therapy included AUGMENTIN.  Her last menstrual period was 29-AUG-2008.  The patient outcome was unknown.  Additional information has been requested.
On 09/11/2023 patient was giving the wrong dose of flu vaccine. She received high dose and needed regular flu. Patient was called and notified of the incident and provider also notified. Was document and manager was notified.
Pure water diarrhea, and it's bad; Short stomach pain; I am not feeling well; This is a spontaneous report from a contactable consumer (patient).   A patient of unspecified age and gender received BNT162B, (Lot number was not reported) via an unspecified route of administration on 24Jul2021 as dose number unknown, single for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced pure water diarrhea, where it was bad and had some short stomach pain, also she was not feeling well on 25Jul2021. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Patient presented to urgent care with very sore arm from elbow to shoulder and a 100 degree temperature on 10-6-2021.  By 10-7-2021 she has reported slightly less pain and a temp of 98.3 degrees.
Pt had a legal complaint. An attorney reported that a male child received 3 doses of Hib-TITER vaccine and one dose of Acel-Imune vaccine (date of immunization not specified). It is alleged that as a result of the exposure to mercury in the vaccine the child developed mercury poisoning. The child developed the following symptoms: "severe" learning disabilities, impairments in social relatedness, language and communication difficulties, abnormal movements, sensory dysfunction, depression, anxiety, hearing loss, "severe" bowel dysfunction, and other "severe" health disorders (not identified). This case was considered serious since these events were medically important in this case. No additional info was available as of the date of this report.
Local reaction=erythema, pruritis at injection site=erythema 3cm around injection site. Currently on Benadryl prn. Recovering.
Systemic: Dizziness / Lightheadness-Medium, Systemic: patient cant control breathing; cant walk after 10 min administration-Medium, Systemic: Flushed / Sweating-Medium
Patient presented to the Hospital Emergency Department with symptoms consistent with COVID-19 and had a positive COVID-19 PCR test. The patient was admitted the hospital Med/Surg unit for treatment of COVID-19 pneumonia.  The patient was fully vaccinated at the time of his positive COVID-19 test.
At approximately 2:30am on 11/17/22 I woke up not feeling good. I had trouble with my balance. I vomited, couldn't sit up or stand, and I had the worst headache of my life. My husband came into the bathroom to check on me and he said I was slurring my words and not making any sense. He called 911.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Medium
localized redness about 3 inch in radius around injection area , visible swelling, itching  on left arm tiredness and severe bodyache
Cannot move my neck/Cannot move my right shoulder/My left gave up on me twice; Cannot move my neck/Cannot move my right shoulder/My left gave up on me twice; This spontaneous case was reported by a patient and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Cannot move my neck/Cannot move my right shoulder/My left gave up on me twice) and MUSCULOSKELETAL DISCOMFORT (Cannot move my neck/Cannot move my right shoulder/My left gave up on me twice) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Cannot move my neck/Cannot move my right shoulder/My left gave up on me twice) and MUSCULOSKELETAL DISCOMFORT (Cannot move my neck/Cannot move my right shoulder/My left gave up on me twice). At the time of the report, MUSCULOSKELETAL STIFFNESS (Cannot move my neck/Cannot move my right shoulder/My left gave up on me twice) and MUSCULOSKELETAL DISCOMFORT (Cannot move my neck/Cannot move my right shoulder/My left gave up on me twice) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Rash, hives about 1 1/2 hours after injection. Swelling in face, eyes on 3/4/2003, rash on back, legs, felt hot and rash on opposite arm. Saw MD on 3/4/2003 recv'd shot - on oral Prednisone.
Bivalent vaccines have undergone several temperature excursions and have been administered to patient; No adverse event; Bivalent vaccines have undergone several temperature excursions and have been administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent vaccines have undergone several temperature excursions and have been administered to patient), POOR QUALITY PRODUCT ADMINISTERED (Bivalent vaccines have undergone several temperature excursions and have been administered to patient) and NO ADVERSE EVENT (No adverse event) in a 49-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Sep-2022 at 2:22 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 22-Sep-2022 at 2:22 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Bivalent vaccines have undergone several temperature excursions and have been administered to patient). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent vaccines have undergone several temperature excursions and have been administered to patient) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent vaccines have undergone several temperature excursions and have been administered to patient), POOR QUALITY PRODUCT ADMINISTERED (Bivalent vaccines have undergone several temperature excursions and have been administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent vaccines have undergone several temperature excursions and have been administered to patient) and POOR QUALITY PRODUCT ADMINISTERED (Bivalent vaccines have undergone several temperature excursions and have been administered to patient).    No concomitant product reported by the reporter. Patient had received previous 3 doses of vaccine, intramuscular with anatomical site as deltoid. Dose 4 anatomical site was also reported as deltoid. Bivalent vaccines stored in the refrigerator that underwent several temperature excursions in August 2022. Refrigeration excursions were identified, state vaccine was housed in the units. There were excursions noted. Manufactures were notified and the state department was made aware of the situation.  No adverse reactions were reported for any of the patients at the time of the report. No treatment medication reported by the reporter.
This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (pain in arm), VERTIGO (Vertigo) and NASOPHARYNGITIS (Cold) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. Concurrent medical conditions included Osteoporosis. Concomitant products included RISEDRONATE SODIUM (ACTONEL) from 02-Feb-2021 to an unknown date for Osteoporosis. On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VERTIGO (Vertigo) and NASOPHARYNGITIS (Cold). On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in arm). At the time of the report, PAIN IN EXTREMITY (pain in arm), VERTIGO (Vertigo) and NASOPHARYNGITIS (Cold) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. No concomitant medication nor treatment information provided.
Important note: I filled out the VAERS form about an adverse reaction, ref # 2587887. They called and asked me to make a separate submission for this adverse reaction. This was patient's first adverse reaction as far as we know, and it was after the booster. He called on Feb. 5, 2022 and said he had a lot of chest pain and was resting. He'd tried to play sports that morning but was unable because he couldn't breathe well. He was still feeling lousy the next day and unable to attend service because of the pain. Honestly, it wasn't until I was praying that night that got through to me and told patient needed to get to the ER because he had pulmonary embolisms. I called patient and he went to the hospital where they did a CT scan and blood work and determined that yes, his lungs were full of clots. They gave him a prescription for eliquis and it took about a week for patient's pain to subside enough for normal activity. He remained on that rx for 6 months. You can read more about the further adverse reaction in the above case number. As far as we know, patient has still never had COVID-19, just four doses of vaccine. He went to Medical Center on the night of Feb 6, 2022, and it took until the morning of Feb 7, 2022 for the tests to be finalized and he was sent home. We then made an appt with his regular doctor to follow up.
Approx. 8 hrs after receiving mom reported arm swelling and warm to touch. Mom stated her arm was twice that of it's normal size. Pt. saw NP in local area, prescribed antibiotic and antihistamine. The NP thought it was more an allergic reaction than a cellulitis.
About 24 hrs after the vaccine I developed body ache, fever, headache, chills and felt very poorly which lasted about 5hrs caused me to lay down but felt better soon. The next day I woke up with a rash on my back, the tops of my arms and a small area on my upper chest.  By day 3 the rash on my back had spread and was extremely itchy.  I took Benadryl and used topical OTC hydrocortisone cream to help, but it got no better so reached out to my PCP who advised another OTC cream, but it too didn't work so a steroid .05% topical cream was prescribed and so far, it is working a little better, but the rash is still there to date, but it is improving
very nauseated; didn't have an appetite; got cold; got hot; Reaction of side effects; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 58 year-old female patient received bnt162b2 (BNT162B2), administered in arm (Lot number: Unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "History of migraines" (ongoing), notes: Verbatim: History of migraines; "Normal seasonal allergies" (not ongoing), notes: Verbatim: Normal seasonal allergies; "diagnosed allergies" (unspecified if ongoing), notes: Patient's Medical History; "compromised immune status" (unspecified if ongoing), notes: Patient's Medical History; compromised immune status; "respiratory illness" (unspecified if ongoing), notes: Patient's Medical History; respiratory illness; "chromosomal abnormalities" (unspecified if ongoing), notes: Patient's Medical History; genetic /chromosomal abnormalities; "endocrine abnormalities" (unspecified if ongoing), notes: Patient's Medical History; endocrine abnormalities; "obesity" (unspecified if ongoing), notes: Patient's Medical History; obesity. Family history included: "cancer" (unspecified if ongoing), notes: Patient's mother's side of the family it was like everyone had gotten cancer. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, Lot/NDC/Expiry: Unknown, Dose: Unknown strength/volume/dose injection to unknown location, caller assumes an arm, at unknown time.), for Covid-19 immunization. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "very nauseated"; DECREASED APPETITE (non-serious), outcome "unknown", described as "didn't have an appetite"; NASOPHARYNGITIS (non-serious), outcome "unknown", described as "got cold"; FEELING HOT (non-serious), outcome "unknown", described as "got hot"; ADVERSE DRUG REACTION (non-serious), outcome "recovered", described as "Reaction of side effects".  Additional information: This is report 2 of 4. Daughter is the patient in this report.Caller's daughter called caller last night and when caller told daughter about her own side effects, daughter mentioned she knew that feeling because she had some of the same type of side effects herself. Caller does not know if patient had every side effect caller had ; but she knows patient was very nauseated, didn't have an appetite, got cold and got hot. No prior vaccinations done within 4 weeks. No AE(s) following prior vaccinations.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a health professional concerning a 24 year old female with pulmonary fibrosis, which was reported to be stable, and recent sinusitis who on 11/8/01 was vaccinated in the left deltoid with a dose of pneumococcal vaccine 23 polyvalent (lot #636159/1070K). Concomitant therapy included sulfamethoxazole/trimethoprim (BACTRIM DS TABLETS) for recent sinusitis, hormonal contraceptives (unspecified), unspecified antihistimines and buspirone hcl (BUSPAR). On 11/9/01, the patient experienced pain, swelling and redness and was scheduled to be seen in the physician's office. The reporter expressed a concern with the lot. The records of testing prior to release of this lot have been checked  and found to be satisfactory. The lot complies with the standards and was released. Another patient (WAES01111206) had a similar experience following exposure to pneumococcal vaccine 23 polyvalent. Follow up information from the health care professional indicated that the patient did not have a real adverse reaction. Additional information has been requested.
About 1 minute after the shot, I passed out and had a ceaser.  I've never had an experience like that before, I've passed out before as a kid from a shot, but not as an adult.  I've passed out before, but this was not the same as any other experience in my life. It was absolutely terrifying.   I was fine during the shot, I was talking to the nurse and suddenly I lost all control over my motor skills and I couldn't control myself.  My eyes rolled to the back of my head and I had a hard time recovering.  My whole body was soaked in sweat, and my mind was blank.   I've never had a ceaser before, I have no known allergies.  I am a drug free, I was not on any medication.   I do take Adderall.  I was there picking up my prescription, but I had been out of Adderall and haven't taken it over 24 hours prior to the vaccine.
chills; difficulty sleeping; pain in arm; fatigue; disoriented; fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), INSOMNIA (difficulty sleeping), PAIN IN EXTREMITY (pain in arm) and FATIGUE (fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PYREXIA (fever). On 27-Feb-2021, the patient experienced CHILLS (chills), INSOMNIA (difficulty sleeping), PAIN IN EXTREMITY (pain in arm), FATIGUE (fatigue) and DISORIENTATION (disoriented). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 28-Feb-2021, PYREXIA (fever), CHILLS (chills), INSOMNIA (difficulty sleeping), PAIN IN EXTREMITY (pain in arm), FATIGUE (fatigue) and DISORIENTATION (disoriented) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medicine was reported.
as if there's a big lump; redness on the injection site for 10 days; swelling on the injection site for 10 days; weight of periodic headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (as if there's a big lump), INJECTION SITE ERYTHEMA (redness on the injection site for 10 days), INJECTION SITE SWELLING (swelling on the injection site for 10 days) and HEADACHE (weight of periodic headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concomitant products included GABAPENTIN, GLUCOSAMINE and VITAMIN D NOS for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE MASS (as if there's a big lump), INJECTION SITE ERYTHEMA (redness on the injection site for 10 days), INJECTION SITE SWELLING (swelling on the injection site for 10 days) and HEADACHE (weight of periodic headache). On 20-Feb-2021, VACCINATION SITE MASS (as if there's a big lump), INJECTION SITE ERYTHEMA (redness on the injection site for 10 days) and INJECTION SITE SWELLING (swelling on the injection site for 10 days) outcome was unknown. At the time of the report, HEADACHE (weight of periodic headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications includes duragesic patch and supplements. No treatment drugs are not provided by reporter.   This case was linked to MOD-2021-187590 (Patient Link).
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. In 2015, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles.  The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 18-JUL-2018, he was treated at a clinic for the onset of severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events were unknown at the time of the report. Causality assessment was related. Additional information has been requested.
10/11/2021 - weakness, nausea, dizziness, inability to sleep,
Generalized urticarial reaction. No vesicles/pustules/afebrile/no lymphadenopathy.
Patient daveloped cellulitis of left arm where DTaP was given. Patient was started on Augmentin and will be followed up.
Feeling faint after vaccination  Vital Signs: BP 150/85 HR 62 Resp 10 O2Sat 96  Skin Signs: Warm and dry  Circulation: >3sec Respiratory: Breath sound clear bilaterally  Initial Treatment: Laying down on cot 1:50 PM. Given 1 juice box, peanuts, water.  2:05 PM Vital Signs: BP 140/90 HR 79 O2Sat 97 Skin Signs: Warm and dry  Circulation: 3sec  Respiratory: Breath sound clear bilaterally  Follow up Treatment: Released to mother  Disposition: Walked to car with mother
Severe body aches, chills, headache, fever 101-102 for 22 hours.
Itching at the injection site; This spontaneous case was reported by a patient and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for an unknown indication.     No Medical History information was reported.    On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided. Treatment medications include Benadryl..   Reporter did not allow further contact